New Report Offers Complete And Concise Overview Of The Vaginal Infections Drug Pipeline
Posted on: Thursday, 27 September 2007, 09:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c69820) has announced the addition of Women's Health - Vaginal Infections Drug Pipeline Report to their offering.
"Women's Health - Vaginal Infections Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of vaginal infections drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits of this report:
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Vaginal Infections Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Vaginal Infections Projects
--Top 20 companies in early stage Vaginal Infections Projects
Full Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c69820
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Innovation Leader Endorses IFT-NPD for Managing Innovation and New Product Development With Stage-Gate(R) Ready Certification Version II Criteria
- TransCanada, Enterprise Products and Quicksilver Gas Services Sign Agreement for Equity and Pipeline Capacity in Pathfinder Pipeline Project
- Sciele Pharma to Webcast Product Development Pipeline Presentation
- Emergent BioSolutions Announces Dr. Stephen Lockhart Joins Company to Lead Commercial Product Development Subsidiary
- GTronix Expanding Product Development Team; Company Appoints New VP of Engineering
- Cranes Software Acquires the Worldwide Marketing & Sales Rights of InventX(TM) ePM; Cranes to Invest in InventX(TM) ePM Project Portfolio Management Solution, Product Development and Life-Cycle Management
- Point Therapeutics Awarded $600,000 Orphan Products Development Grant to Fund Company's Current Phase 2 Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia
- Nymox Continues to Successfully Expand Extensive Patent Portfolio; Nymox's Product Development Pipeline Based on Several Hundred Patents and Applications Worldwide
- Actify Enters Microsoft's Collaborative Product Development Program
 |
 |
User Comments (0)
RSS Feeds